PD-MitoQUANT publication news from Dr Daniele Bano, DZNE

2022-04-01T17:52:45+01:00March 22nd, 2022|Partner in the Spotlight, Publication|

Dr Daniele Bano Congratulations to Antonia Piazzesi, Yiru Wang, Joshua Jackson, Lena Wischhof, Viktoria Zeisler-Diehl, Enzo Scifo, Ina Oganezova, Thorben Hoffmann, Pablo Gomez Martın, Fabio Bertan, Chester J J Wrobel, Frank C Schroeder, Dan Ehninger, Kristian H€andler, Joachim L Schultze, Lukas Schreiber, Gerhild van Echten-Deckert, Pierluigi Nicotera and Daniele Bano of the German Center for Neurodegenerative Diseases (DZNE) ! Their study 'CEST-2.2 overexpression alters lipid metabolism and extends longevity of mitochondrial mutants' was published in EMBO Reports on March 17th, 2022, e52606 [...]

DZNE Postdoc Hannah Scheiblich interview with the Neuronet project

2022-03-21T09:11:38+00:00March 21st, 2022|News, Partner in the Spotlight|

German Center for Neurodegenerative Diseases (DZNE) Postdoc Hannah Scheiblich was interviewed by the Neuronet project (https://www.imi-neuronet.org/) on October 13th, 2021. Dr Scheiblich discusses her career, research and the challenges and opportunities existing in her field as part of the continuing series of early-stage researcher interviews. Read the full story here. The Neuronet initiative has been conceived to link IMI projects in order to promote collaboration and to raise the visibility of research findings. Neuronet also aspires to support other initiatives and researchers from all [...]

Parkinson’s Research in Ireland 2022 event announced

2022-03-22T13:47:45+00:00March 7th, 2022|News|

The popular online event series to share information about Parkinson's Research in Ireland continues in 2022! To celebrate Parkinson's Awareness Month, we have assembled a varied array of speakers for short online talks for education, information and conversation surrounding the latest Parkinson's research. The two-night event kicks off March 31st from 6-7 PM and subsequently on April 7th, 2022 also 6-7:00. Our own project Deputy Coordinator Niamh Connolly, RCSI and Richard Campbell representing Parkinson's UK will headline on the first [...]

Our March 2022 newsletter is published

2022-03-02T14:33:36+00:00March 2nd, 2022|News, Partner in the Spotlight|

Our latest newsletter has been published. In our first in 2022, read RCSI Prof. Jochen Prehn's message and research update and learn about our partner UCB and their role in PD-MitoQUANT. The spotlight shines on Radboud University Nijmegen Medical Center this month; learn about their research in mitochondrial morphofunction. Page 4's Dissemination Round-up includes where and how we are sharing our new knowledge. Enjoy!

PROJECT FACTS

 

  • Grant agreement number 821522
  • IMI2 JU contribution €4,617,933.75
  • Duration 36 months
  • Starting date 1 February 2019

 

FUNDING ACKNOWLEDGEMENT

 

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821522. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

The material presented and views expressed here reflect the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

Go to Top